Skip to content

Top navigation

Log In

CoMeCT
Contact

Main Navigation

Project
- Mission
- History
- Members
Toolkits
- Resources
- CDR
- eCRF
Research
- Working Groups
- Publications
News & Events
Central Data Repository

Log In

CoMeCT
Contact

Intervention: Nirmatrelvir/Ritonavir

PanoramicNOR

Norway

|

2023-2026

Adults
General population
SARS-CoV-2
Post-COVID-19
Pharmacological intervention
Antivirals
Nirmatrelvir/Ritonavir

Mazzitelli

Italy

|

2022-2022

Adults
Elderly
General population
Hospital wide
Outpatient clinic
SARS-CoV-2
Acute SARS-CoV-2
Pharmacological intervention
Antivirals
Nirmatrelvir/Ritonavir
Molnupiravir

ESOA-19

Portugal

|

2022

Adults
Elderly
General population
Hospital wide
Outpatient clinic
SARS-CoV-2
Acute SARS-CoV-2
Pharmacological intervention
Antivirals
Nirmatrelvir/Ritonavir
Molnupiravir

Evans

United Kingdom

|

2021-2022

Adults
Elderly
Fragile population
Outpatient clinic
Non-hospital health centre
Community
SARS-CoV-2
Acute SARS-CoV-2
Pharmacological intervention
Monoclonal antibodies
Sotrovimab
Antivirals
Nirmatrelvir/Ritonavir
Molnupiravir

Home
Project
Toolkits
Research

CDR
Contact
CoMeCT

Cohorts Coordination Board

The CCB is a board that aims to encourage knowledge-sharing between cohort-based research projects to facilitate partnerships, discuss similar challenges and reduce overlap between projects.

This work is part of the VERDI project (101045989), which is funded by the European Union.

Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

Terms
Privacy
Cookies

Developed by La Tempesta